Cell-free production of site-specifically phosphorylated proteins

Ended Definitive Contract Awarded Last action

Contract number
HHSN261201400031C
Awardee
Awarding agency
Obligated
$148,916

Award facts

Opportunity
Contract value 100% obligated
$148,916.00 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
Set-aside
No set-aside
Competition
Full and Open Competition · 8 offers Negotiated Proposal / Quote
Pricing
Firm Fixed Price
Place of performance
Potomac, MD 20854, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Other Administrative Action 1 · Other function - cell-free production of site-specifically phosphorylated proteins $0
Original award $148,916

About this award

The National Cancer Institute (NCI) awarded a $148,916.00 firm-fixed-price definitive contract to Rana Bioscience, Inc., a minority-owned, for-profit manufacturer of goods, for the "CELL-FREE PRODUCTION OF SITE-SPECIFICALLY PHOSPHORYLATED PROTEINS." The contract was awarded on September 19, 2014 with an ultimate completion date of August 18, 2015. The contract was not set aside for any specific business type.

Quick answers

Who was awarded contract HHSN261201400031C?

HHSN261201400031C was awarded to Rana Bioscience, Inc. by National Cancer Institute (National Institutes of Health) on September 19, 2014.

How much is contract HHSN261201400031C worth?

The government has obligated $148,916 on HHSN261201400031C.

Was contract HHSN261201400031C competed?

The extent of competition for HHSN261201400031C was full and open competition. The government received 8 offers.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award